Riskpilot← Back to searchSign inGet full accessATTENDS AS
ASActiveOrg 980609162Badstugata 7, 0183 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 199910 employeeswww.attends.no
Revenue 2024
NOK 145,3M
+12% vs 2023
EBITDA margin
2.2%
+7% vs 2023
Equity ratio
70.1%
Financial strength
Net profit 2024
NOK 3,8M
+62% vs 2023
| Revenue | NOK 145,3M | +12% |
| EBITDA | NOK 3,2M | +7% |
| Net profit | NOK 3,8M | +62% |
| Total assets | NOK 48,9M | +6% |
| Equity | NOK 34,3M | +13% |
| Employees | 10 | — |
Legal name
ATTENDS AS
Org number
980609162
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. mars 1999
Share capital
—
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Address
Badstugata 7, 0183 Oslo
Phone
+4723272290
Email
info@attends.no
Website
www.attends.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 85 801 | 112 334 | 113 696 | 130 164 | 145 291 |
| Staff expenses | −6 766 | −7 573 | −11 308 | −8 455 | −10 319 |
| EBITDA | 2 060 | 2 372 | 932 | 2 987 | 3 206 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −2 |
| EBIT | 2 060 | 2 372 | 932 | 2 987 | 3 205 |
| Net financials | 6 | −10 | 25 | 108 | 1 756 |
| Profit before tax | 2 065 | 2 363 | 956 | 3 095 | 4 961 |
| Tax | 466 | 534 | 219 | 720 | 1 114 |
| Net profit | 1 600 | 1 829 | 738 | 2 376 | 3 847 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 37 928 | 39 672 | 41 261 | 46 156 | 48 889 |
| Equity | 25 470 | 27 299 | 28 037 | 30 412 | 34 259 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 12 458 | 12 373 | 13 225 | 15 744 | 14 630 |
| Total debt | 12 458 | 12 373 | 13 225 | 15 744 | 14 630 |
EBITDA margin
2.2%
This company
15.8%
Market median
-86% vs market
20202024
Equity ratio
70.1%
This company
38.2%
Market median
+84% vs market
20202024
Return on equity
11.2%
This company
18.4%
Market median
+39% vs market
20202024
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20202024
Asset turnover
2.97×
This company
1.12×
Market median
+165% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
EB Chief Executive Officer | Chief Executive Officer | 2000 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Attends Healthcare Ab | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ATTENDS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Banks | Chief Executive Officer | 0 companies |
| Emilio Barta Perez | Board of Directors | 0 companies |
| Mattias Robert Wilner | Chairman | 0 companies |
| Anna Clara Soedergren | Board of Directors | 0 companies |